Pyrrolo-pyridine kinase modulators

作者: Ruo W. Steensma , Mark E. Wilson , William D. Arnold , Pierre Bounaud , Ian Mcdonald

DOI:

关键词:

摘要: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the to treat diseases mediated by activity.

参考文章(95)
Steven M Kornblau, Michael Andreeff, Michele Milella, The mitogen-activated protein kinase signaling module as a therapeutic target in hematologic malignancies Reviews in Clinical and Experimental Hematology. ,vol. 7, pp. 160- 190 ,(2003)
Ingeborg Feil, David Lorber, Yi Liu, Sean G. Buchanan, Kai W. Post, Stephen S. Antonysamy, Crystals and structures of pak4kd kinase pak4kd ,(2003)
Raymond Baker, Neil Roy Curtis, Adrian Leonard Smith, Janusz Jozef Kulagowski, Paul David Leeson, Mark Peter Ridgill, Pyrrolo-pyridine derivatives ,(1994)
Nicholas A. Meanwell, Zhongxing Zhang, Qiufen May Xue, Tao Wang, John F. Kadow, Indole, azaindole and related heterocyclic pyrrolidine derivatives ,(2003)
Michael Gerard Kelly, William Joseph Lennox, Derek Cecil Cole, Ping Zhou, Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands ,(2001)
Vanessa Eisai London Res. Lab. Ltd. Palmer, Piotr Eisai London Res. Lab. Ltd. Graczyk, Afzal Eisai London Res. Lab. Ltd. Khan, Hirotoshi Numata, 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders ,(2003)
Piotr Pawel Eisai London Res. Lab. Ltd. Graczyk, Gurpreet Singh Eisai London Res.Lab. Ltd. Bhatia, Darren Peter Eisai London Res. Lab. Ltd. Medland, 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors ,(2005)
Kostas Karabelas, Peter Sjö, Matti Lepistö, New pharmaceutically active compounds ,(1997)
Ruo W. Steensma, Mark E. Wilson, William D. Arnold, Andreas Gosberg, Zhe Li, Fused ring heterocycle kinase modulators ,(2008)
Julian M. C. Golec, Ronald Knegtel, Hayley Binch, Francoise Pierard, Jean-Damien Charrier, David Kay, David Bebbington, Andrew Miller, Simon Everitt, Compositions useful as inhibitors of protein kinases ,(2004)